Main Content

Press Release


ELEKTA RECEIVE ORDER FOR COMPLETE IMPAC IT SOLUTION TO UNIVERSITY HOSPITALS COVENTRY & WARWICKSHIRE NHS TRUST

PRESS RELEASE
Stockholm, January 31, 2006

Elekta, a world leader in advanced radiation therapy, comprehensive cancer management and non-invasive treatment of brain disorders, today announced an order from University Hospitals Coventry & Warwickshire NHS Trust for a comprehensive oncology management system from IMPAC Medical Systems, a part of the Elekta Group and a leading provider of information technology solutions for oncology care. This single-database oncology-specific image-enabled electronic medical record (EMR) will help the Trust to provide better care for cancer patients living in Coventry, Warwickshire and beyond.

IMPAC’s integrated software system helps improve overall treatment and practice management across the spectrum of cancer care by streamlining diagnostic and treatment information, charge capture and billing, and scheduling information into a patient chart that is instantly accessible from remote locations by hospital staff.

With the new information management solution, The Arden Cancer Centre in the new University Hospital will now be able to obtain an integrated real-time link to all the clinics in the cancer network, as far a field as Redditch, Warwick, Rugby, Solihull and Nuneaton as well as across the whole of the Trust.

Availability of the Trust’s and the Cancer Network’s integrated system enables a cancer patient to be admitted into the Emergency Department where the staff will have instant access to the patient's record. The staff will immediately know the patient’s diagnostic, chemotherapy or radiotherapy treatment information. This allows the emergency staff to provide continuity of treatment to best meet the patient's needs.

The contract for the new system and implementation was signed on Monday, January 30, in the presence of hospital staff and representatives from the Elekta Group, IMPAC’s parent company.

Arden Cancer Centre Superintendent Radiographer, Bill Kelly, said: "The new system has many benefits for both the patient and staff alike. We will have all of the patient's information, in one single system including x-rays and this will be available for the consultant, radiographer, pharmacist or anyone else involved in the patient's care to instantly access the patient’s medical record."

The system can also be used to electronically schedule and prescribe chemotherapy sessions, making treatment safer and more efficient, while improving waiting times by making best use of both staff and equipment. Having this information at the touch of a button will also facilitate clinical trials, and aid in research into the causes and treatment of cancer.

Elekta is already the sole provider of digital linear accelerators and related radiation therapy technology to the Arden Cancer Network. With the introduction of the IMPAC system, the hospital confirms its position as a center of excellence for cancer management and leading edge technologies, keeping the Trust at the forefront of cancer management and treatment delivery across the UK and Europe.

“IMPAC are both delighted and proud to be working with UHCW. We believe that this is the first and largest truly integrated comprehensive oncology information management solution to be delivered to an NHS Trust”, said Stewart Pegrum,
Sales Manager, IMPAC UK. “Our collective drive, vision and passion for the delivery of premium cancer treatments will lead the way in cancer service delivery within the UK.”

******

For further information, please contact:

Peter Ejemyr
Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000
e-mail: peter.ejemyr@elekta.com

University Hospitals, Coventry & Warwickshire NHS Trust
Communications Department
+44 2476 535987 or +55 2476 535900

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 1750 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


About IMPAC Medical Systems, Inc.

IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC’s products or services, please call 1-650-623-8800 or visit www.impac.com.


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download:


PDF